Hematologic aspects of renal insufficiency.

Area of Science:

• Nephrology
• Hematology

Background:

• Renal dysfunction leads to significant hematologic issues, including anemia, impaired leukocyte function, and coagulopathy.
• The anemia of renal failure is multifactorial, involving erythropoietin deficiency, iron/folate deficiency, heavy metal toxicity, blood loss, and hemolysis.

Purpose of the Study:

• To discuss the pathophysiology of hematologic disturbances in uremia.
• To outline therapeutic recommendations for anemia, bleeding, and infectious complications in renal failure.

Main Methods:

• Review of existing literature on the hematologic complications of renal disease.
• Discussion of pathophysiological mechanisms.
• Synthesis of current therapeutic strategies.

Main Results:

• Anemia in renal disease can be treated with recombinant human erythropoietin, potentially normalizing hemoglobin levels.
• Platelet dysfunction in renal disease is primarily managed by dialysis, with cryoprecipitate or DDAVP as alternatives.
• Infectious complications involve impaired leukocyte function, cell-mediated immunity, and hypogammaglobulinemia.

Conclusions:

• Modern treatments, including recombinant human erythropoietin and dialysis, have significantly improved the management of renal failure's hematologic complications.
• Understanding the underlying pathophysiology is crucial for effective therapeutic interventions.
• Further research may refine treatments for bleeding and infectious issues in uremic patients.